DE1491218A1 - Highly porous collagen tissue blood vessel prosthesis and method for producing the same - Google Patents
Highly porous collagen tissue blood vessel prosthesis and method for producing the sameInfo
- Publication number
- DE1491218A1 DE1491218A1 DE19631491218 DE1491218A DE1491218A1 DE 1491218 A1 DE1491218 A1 DE 1491218A1 DE 19631491218 DE19631491218 DE 19631491218 DE 1491218 A DE1491218 A DE 1491218A DE 1491218 A1 DE1491218 A1 DE 1491218A1
- Authority
- DE
- Germany
- Prior art keywords
- tube
- collagen
- blood vessel
- highly porous
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/062—Apparatus for the production of blood vessels made from natural tissue or with layers of living cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Laminated Bodies (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Description
I -' - ' ; ι ; pötti.-igen, den 9,12.1963I - '-'; ι; pötti.-igen, 9.12.1963
Meine Akte» 9566 s/My files »9566 s /
' SPO?A, Sji3?u2fenf podniKu pro zdravotniGkoUjTyrobu, Praiia (0S3R)'SPO? A, Sji3? U2fenf podniKu pro zdravotniGkoUjTyrobu, Praiia (0S3R)
Hoohporöse Kollajjen-Gewebe-Blutsefassprotneae und Verfauron zur -rierotellung derselben.High-porous Kollajjen tissue blood-catching protneae and Verfauron to -rierotstellung the same.
Die Erfiadung betrifft eine hoohporöse Kolla^en-Gevvebe-Blut^efüssprot-iQse und, ein Verfahren zur herstellung derselben·The experience concerns a high porous collagen-Gevvebe-Blood-Feet-Prot-iQse and, a process for making the same
Wie bekannt werden in der klinischen Praxis der Blutgefässohirur^jie zuru Ersetzen von resezierten Blutgefaasen Prothesen, welche aus verschiedenen, physiologisch inerten Kunstfasergeweben (Teflon, Dacron usw.) hergestellt sind, verwendet» Die Wand-As is well known in clinical practice, the blood vessel surgeon ^ jie to replace resected blood vessels prostheses, which are made of different, physiologically inert synthetic fiber fabrics (Teflon, Dacron, etc.), used »The wall
porösität solcher Prothesen beträgt etwa 15oo-2ooo ml Hg "in. bei einem Druok von 12o mm Hg. Die Konstruktion von 31ut- ^eXässprothesen mit höherer V/andporöaität /5ooo - lo.ooo ml ii^O/om^/i.in./, welche gemäss Forsohungser^ebniiisen für das weitere Gcij-icksal des implantierten Blutgefänsersatzey von Grundl»euGutun{ä ist, wird durch Kombination einerj resorbierbaren Hatorials mit einer dünnen Gewebeprotlieoe gelöst. Das reöorbierbaro tutorial hat nämlich die Aufgabe,während des HeilprozesEies die llutung dui*cii die Maschen des Kunstfaser^ewebes zu verhindern. porosity of such prostheses is about 150-2000 ml Hg "in. at a pressure of 12o mm Hg. The construction of 31ut- ^ eXässprothesen with higher V / andporöaität / 5ooo - lo.ooo ml ii ^ O / om ^ / i.in. /, which according to Forsohungser ^ ebniiisen for the further The fate of the implanted blood vessel set from Grundl »euGutun {ä is solved by combining a resorbable hatorial with a thin tissue protlieoe. The re-absorbable The task of the tutorial is during the healing process the lutung dui * cii to prevent the meshes of the synthetic fiber ^ ewebes.
909814/0057 bad original909814/0057 bad original
-2- H91218-2- H91218
Als resorbierbares Material wurden bisiier folgende Stoffe benutz* Catgutfaser, gegebenenfalls mit Kunstfasern zusammengewirkt oder —gewebt, amorphe Gelatine, Kollagenfilm in Form einer Röhre zusammengenäht* Die experimentelle Erprobung solcher Prothese war im Wesentlichen erfolglos mit Rücksicht darauf, dass die Versuchstiere grösstenteils (über 5o#) ausgeblutet - · waren. Ein kompliziertes Herstellungsverfahren und die Unmöglichkeit der durchlaufenden Qualitätskontrolle bei der Serienproduktion stellen weitere Fachteilβ dieser Methode dar.The following substances have been used as absorbable material * Catgut fiber, possibly combined or woven with synthetic fibers, amorphous gelatin, collagen film in the form of a Tube sewn together * The experimental testing of such The prosthesis was essentially unsuccessful considering that the test animals mostly bled out (over 50 #) - was. A complicated manufacturing process and the impossibility of continuous quality control in series production represent a further part of this method.
Es ist durch die vorliegende Erfindung gelungen, die genannten Mangel duroh Konstruktion einer hochporösen Kollagen-Gewebe-Blut^efässprothese gemäss Erfindung und duroh ein Verfahren zur Herstellung derselben zu beseitigen«,The present invention succeeded in achieving the aforementioned Deficiency due to the construction of a highly porous collagen-tissue-blood vessel prosthesis according to the invention and by eliminating a process for the production of the same «,
Diese Prothese, bestehend aus einer Röhre, hergestellt aus einem nichtresorbierbaren, physiologisch inerten Kunstfasergewebe, mit einer WandporTteität über 2000 ml ll^O/ma. /Min. bei einem Druck von 12o mm Hgf kombiniert mit dinem resorbierbaren Stoff, wie Catgut, Gelatine oder Kollagen, kennzeichnet, sichüra Wesentlichen darin, dass die aus einem nicht resorbia?- baren, physiologisoh inerten Kunstfasergewebe hergestellte Röhre die äussere Sohioht der Blutgefässprothese und eine selbsttragende Röhre, hergestellt aus einer Kollagenmasse, derer Resorbierbarkeit duroh teilweise ohemisohe Härtung modifiziert ist, die innere gohioht bildet, wobei die innere Oberfläche der Kollagenröhre mit einem Antikoagulationsmittel präpariert ist.This prosthesis, consisting of a tube, made of a non-resorbable, physiologically inert synthetic fiber fabric, with a wall porosity of over 2000 ml . / Min. at a pressure of 12o mm Hg f combined with a resorbable substance such as catgut, gelatine or collagen, is characterized essentially by the fact that the tube made of a non-resorbable, physiologically inert synthetic fiber fabric is the outer surface of the blood vessel prosthesis and a self-supporting one Tube made of a collagen mass, the absorbability of which is modified by partially ohemisous hardening, forms the inner gohioht, the inner surface of the collagen tube being prepared with an anticoagulant.
BAD ORIGINAL 9098U/0057 BATH ORIGINAL 9098U / 0057
U91218-U91218-
Diese Blutgefässprotheae kennzeichnet sioh ferner darin, dass ·" ihre innere Sohiaht eine Röhre bildetf die hergestellt ist aus einer mit Muoopolysaoohariden und/oder Glyoerin und/oder mit einem oder mehreren Antibiotioa angereioherten Kollagenmasse, wobei diese Komponenten entweder einzeln oder in verschiedenen Kombinationen zugesetzt werden k'önnene This Blutgefässprotheae features SiOH further that · "their inner Sohiaht forms a conduit f which is fabricated from a with Muoopolysaoohariden and / or Glyoerin and / or with one or more Antibiotioa angereioherten collagen mass, where these components can either be added individually or in various combinations can e
Eine weitere Ausbildung der Erfindung besteht darin, dass sioh zwischen der äusseren Kunstfasergewebesohicht und der inneren, aus einer chemisch modifizierten Kollagenmasse hergestellten Schicht, eine Zwisohensohioht aus einer amorphen, nativen chemisch nicht modifizierten Kollagenmasse befindet·Another embodiment of the invention consists in that sioh between the outer synthetic fiber fabric layer and the inner, made of a chemically modified collagen mass, an intermediate layer made of an amorphous, native one chemically unmodified collagen mass is located
Bei der etfindungsgemässen Herstellung der hooliporösen Blutgefässprothesen kann man ZeB0 so verfahren, dass man 'zunäohst desintegrierte und homogenisierte Kollagenmasse, zubereitet durch alkalische Quellung des Rind-Leimgallertgewebes, gegebenenfalls vermischt mit Muoopolysaoohariden und/oder Glyoerin und/oder mit einem oder mehreren Antibiotioa, in Form einer Röhre gestaltet, die man nachher in feuohtem oder trockenem Zustand mit einer hoohporösen O-eweberöhre überzieht, worauf man die innere Fläohe der Kollagenröhre duroh Einwirkung eines Härtungsmittels ohemisoh modifiziert und nach Auswaschen des Härtungemittele mit einem Antikoagulationsmittel präpariert·In the production of the hooliporous blood vessel prostheses according to the invention, ZeB 0 can be done in such a way that initially disintegrated and homogenized collagen mass, prepared by alkaline swelling of the beef glue gelatinous tissue, optionally mixed with muoopolysaoohariden and / or glycerin and / or with one or more antibiotics In the form of a tube, which is then covered in a wet or dry state with a porous O-tissue tube, whereupon the inner surface of the collagen tube is modified ohemisoh by the action of a hardening agent and, after washing out the hardening agent, is prepared with an anticoagulant
Eine besonders feste Verbindung beider Röhren kann man daduroh erzielen, dass man die hoohporöse Geweberöhre an der Kollagen-A particularly firm connection between the two tubes can be achieved achieve that the high-porous tissue tube on the collagen
röhre mit Hilfe einer duroh Bespritzen oder Anstreichen aufgetragenen Zwischenschicht aus amorpher, nativer, chemisch nicht modifizierter Kollagenmasse fixiert.tube with the help of a duroh spray or paint applied Fixed intermediate layer of amorphous, native, chemically unmodified collagen mass.
Die auf vorstehendem Wege hergestelltehoohporöse Blutgefässprothese lässt sich ohne Gefahr einer unmittelbaren oder später auftretenden , !kangdauerndeu Blutung durch die Prothesenwand implantieren. Bei der klinischen Anwendung, sind weder besondere Massnahmen noch ein spezielles Arbeitsverfahren bei der Operation erforderlich. Aus den bisherigen analogischen Forschungsergebnissen auf diesem Gebiet geht hervor, dass die hohe Porösität des nicht resorbierbaren Bestandteiles der erfindungsgeinässen Prothesen wesentlich bessere Resultate bei der Blutgefässrekonstruktion gewährleistet als es mit dem bisher benutzten Ersatzmaterial möglich war· .The high-porous blood vessel prosthesis manufactured in the above way can be carried out through the wall of the prosthesis without the risk of immediate or later occurring permanent bleeding implant. In clinical use, neither special measures nor a special working procedure are required Surgery required. The previous analogical research results in this area show that the high porosity of the non-absorbable component of the invention Prostheses ensure significantly better results in blood vessel reconstruction than with the previously used one Replacement material was possible ·.
Das Anbringen der resorbierberen selbsttragenden Röhre im Inneren der Kunstfasergeweberöhre lässt die Maschen des Gewebes relativ frei, so dass rasches Durohwaohsen der umliegenden Blutgefässzellgewebe erfolgen kann, ohne dass vorherigerAbbau des resorbierbaren Bestandteiles notwendig wäre· Die blutge-The attachment of the absorbable self-supporting tube in the Inside the synthetic fiber fabric tube leaves the meshes of the fabric relatively free, so that the surrounding area can be swiftly expanded Blood vessel cell tissue can take place without prior degradation of the absorbable component would be necessary
• rinnungshemmende Wirksamkeit der inneren Oberfläche verhindert die Bildung von Thromben. Ein weiterer Vorteil liegt darin, dass man biologische Eigenschaften des Materials aur Herstellung von Blutgefässprothesen gemäes Erfindung dank grosser ohemieoher Reaktivität der Kollagenmasse je nach Bedarf neuen Forschung*- ergebnissen anpassen kann. Das ist besondere für das Einwachsen des niohi resorbierbaren Bestandteiles und für die !Neubildung• Prevents the inner surface from having an anti-coagulant effect the formation of thrombi. Another advantage is that it has biological properties of the material for its manufacture of blood vessel prostheses according to the invention thanks to great ohemieoher Collagen mass reactivity as required by new research * - can adjust results. This is special for waxing of the niohi absorbable component and for the new formation
9098U/00579098U / 0057
U91218U91218
der. Blutgefässwänd wichtig. Durch chemische Härtung der Kolla-"genröLre lüsst si'Oh auch ihre Eesorptionsdauer beeinflussen und standardisieren, so dass keine vorzeitige Resorption dieser Röhre erfolgen kann·the. Blood vessel walls are important. By chemical hardening of the collagen tubes lets si'Oh also influence their absorption duration and standardize so that no premature resorption of this tube can occur
Das naousteilende Beispiel soll die Erfindung näher erläuternf ohne sie zu. be so kränken. The naousteilende example will illustrate the invention f without it. be so offended.
Das folgende Beispiel beschreibt das Erfiudungsneseutliche an einer AuBfiüirüngsforin der Erfindung«The following example clearly describes the invention an execution form of the invention "
Kollagenmasse, zubereitet durch alkalische ^uellu g des Rind-XeiKigallertgev/ebes, wird desintegriert und gründlich homogenisiert ^z.'B.' 24 Stunden lang in einem Homogenisator) und dann 24- otuhden lang in einem Kühlschrank bei 0-4 0 sich seibot belasten« Diese, auf vorstehendem Wege behandelte KoI-lageiiKariije kann man sonon zur Erzeugung von resorbierbaren, selbsttragenden Röhren, welche als Bestandteil einer kombi-* nierten iioohporösen Blutgefässprothese dienen, verv/enden«Collagen mass, prepared by alkaline uellu g of beef XeiKigallertgev / ebes, is disintegrated and thoroughly homogenized ^ e.g. 'B.' In a homogenizer for 24 hours) and then for 24- otuhden in a refrigerator at 0-4 0 itself seibot burden «This KoI-lageiiKariije treated in the above way can sonon be used to produce absorbable, self-supporting tubes, which serve as a component of a combined iioohporous blood vessel prosthesis, are used "
i^ ^oI-l'a enaia'.se ',.ann man auch get:e ^Θΐ£«ηΓί Ils durch Vermis'j:.f:i tiit Iiucopolyn^cchariden, z.B^ vom Typuis dor tl;raluronsäure (0,5 - 3,0;i), mit Glycerin (0,5 - 5,055>)oder mit /-ntibiotioa, J4»B. mit Chlortetracyklin (1 - 5 g/100 g' Mause), Tieomyoin (0,5 - 5 g/10Q g Masse) oder Baoitracin (10«000 - 50.000 E. lic. c Tanse) anreioiiern. Die genannt· η Komponente η kann man entv/odor einzeln· oder in verncxiiedenen Kombinationen zusetzen.i ^ ^ oI-l'a enaia'.se ', .ann one also ge t: e ^ Θΐ £ «ηΓί Ils by Vermis'j: .f: i tiit Iiucopolyn ^ cchariden, eg ^ from Typuis dor tl; r aluronic acid (0.5 - 3.0; i), with glycerine (0.5 - 5.055>) or with / -ntibiotioa, J4 »B. enrich with chlortetracycline (1 - 5 g / 100 g of mouse), tieomyoin (0.5 - 5 g / 10% g mass) or baoitracin (10,000 - 50,000 E. lic. c Tanse). The component η mentioned can be added either individually or in cross-linked combinations.
Au» χ ν -'luf diene Vieiee aufgearbeiteten Kollageniaanse wirdAu "χ ν -'luf serve Vieiee reclaimed Kollageniaanse is
909914/0057 bad original909914/0057 bad original
H91218H91218
dann in einer iuit rotierendem Ziehkopf versehenen Presämaschine duroli Sußarai-;ii.'·: in":en und Verbindung einzelner Pas- rn eine Röhre mit gew: nscutiuu Dur comes, er (zoßo 9 nun) und Wandstärke ( z.B. 0,4- - 0,6 nun) -^ezojbn, und zv;?r unter gleichzeitigem Durchblasen von Luft, ZoBo unter 40 - 150-mm Wassersäuledruck. Die fertige Röhre trocknet man dann langst ia bei einer Temperatur von 15 25° O in mildem Luftstrom« Nach Trocknen überzieht man die Kollagenröhre mit Hilfe einer speziellen Vorrichtung mit der Kunstfasergeweberöhre, worauf man sie von innen mit einer l#-igen wässerigen 2, 4· , 6- Trimethoxytriazinlösung, nachher mit überschüssigem destilliertem Wasser und schliesslich mit einer Lösung eines geeigneten .Antikoagulationsmittels, z.B. mit einer Vi'o -igen wässrigen lieparinlösung durchwischto> Die herstellung der Blutgefassprotiiese beendigt man durch Trocknen unter bereits erwähnten Bedingungen« Durch Luftüberdruck in der inneren Röhre während de3 Trocknens wird eine feste Verbindung beicer Sohicxiten erzielt,, Diese Verbindung -kann man auch so verstärken, indem nisn zwischen beide Schichten eine dinne Zwischenschicht aus amorpher, natifyer, chemisch nicht modifizierter Follt'gen-1U..1 a.:e aufträgt „then provided in a iuit rotating pulling head Presämaschine duroli Sußarai-; ii '·. in ": s and connecting individual Pas-rn a tube with wt: nscutiuu major comes, he (z o ß o 9 now) and wall thickness (for example, 0 , 4- - 0.6 now) - ^ ezojbn, and zv;? R while blowing air through it, ZoBo under 40-150 mm water column pressure. The finished tube is then dried for a long time, generally at a temperature of 15-25 ° O in After drying, the collagen tube is covered with the synthetic fiber tube using a special device, whereupon it is covered from the inside with an aqueous 2, 4, 6-trimethoxytriazine solution, then with excess distilled water and finally with a solution of a .Antikoagulationsmittels suitable, for example, strength with a Vi'o aqueous lieparinlösung by wipes o> manufacturing of Blutgefassprotiiese to quit by drying under conditions already mentioned "by air pressure in the inner tube during drying, a de3 A firm connection between sohicxites is achieved, This connection can also be strengthened by applying a thin intermediate layer of amorphous, natural, chemically unmodified Follt'gen-1U..1 a .: e between the two layers.
Dio fertige Blutgefässprotuese wird dunn in eirtfhluftdiehten UmSOiLLa1Y, ζ.Γ.. in eine Glassampulle eingeschlossen und mit G-amma-Strahlung (z.B. in einer Gabe von 2<.1O r 5' Stunden 1 ng) sterilisiert.Dio is finished Blutgefässprotuese Dunn .. included in eirtfhluftdiehten UmSOiLLa 1 Y, ζ.Γ in a glass ampoule and G-amma-radiation sterilized (for example in a dose of 2 <.1O r 5 'hours 1 ng).
ORIGINALORIGINAL
9098U/00579098U / 0057
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS564463 | 1963-06-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
DE1491218A1 true DE1491218A1 (en) | 1969-04-03 |
DE1491218B2 DE1491218B2 (en) | 1972-06-08 |
DE1491218C3 DE1491218C3 (en) | 1973-01-04 |
Family
ID=5401669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1491218A Expired DE1491218C3 (en) | 1963-06-15 | 1963-12-12 | Blood vessel prosthesis and method for making the same |
Country Status (6)
Country | Link |
---|---|
US (1) | US3425418A (en) |
BE (1) | BE649183A (en) |
BR (1) | BR6355428D0 (en) |
CH (1) | CH472219A (en) |
DE (1) | DE1491218C3 (en) |
GB (1) | GB1018288A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4416028A (en) * | 1981-01-22 | 1983-11-22 | Ingvar Eriksson | Blood vessel prosthesis |
FR2558720A1 (en) * | 1984-01-30 | 1985-08-02 | Meadox Medicals Inc | SYNTHETIC VASCULAR GRAFT, PROCESS FOR PREPARING SUCH A DISTRIBUTION GRAFT OF A MEDICAMENT COATED WITH COLLAGEN AND THINNING FOR FORMING THE SAME |
EP0183365A2 (en) * | 1984-11-30 | 1986-06-04 | Vascutek Limited | Vascular graft |
EP0230635A2 (en) * | 1985-12-24 | 1987-08-05 | Sumitomo Electric Industries Limited | Tubular prosthesis having a composite structure |
EP0237037A2 (en) * | 1986-03-12 | 1987-09-16 | B. Braun Medical AG | Vascular prosthesis impregnated with cross-linked gelatin and method of making the same |
US5716660A (en) * | 1994-08-12 | 1998-02-10 | Meadox Medicals, Inc. | Tubular polytetrafluoroethylene implantable prostheses |
US5851230A (en) * | 1994-08-12 | 1998-12-22 | Meadox Medicals, Inc. | Vascular graft with a heparin-containing collagen sealant |
US5986168A (en) * | 1995-04-25 | 1999-11-16 | Nicem, Ltd. | Prosthesis containing bioabsorbable materials insolubilized without chemical reagents and method of making the same |
US6129757A (en) * | 1998-05-18 | 2000-10-10 | Scimed Life Systems | Implantable members for receiving therapeutically useful compositions |
WO2011012178A2 (en) | 2009-07-31 | 2011-02-03 | Aesculap Ag. | Tubular implant for replacing natural blood vessels |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3526005A (en) * | 1967-06-29 | 1970-09-01 | Gulf General Atomic Inc | Method of preparing an intravascular defect by implanting a pyrolytic carbon coated prosthesis |
US3688317A (en) * | 1970-08-25 | 1972-09-05 | Sutures Inc | Vascular prosthetic |
US3710777A (en) * | 1970-12-23 | 1973-01-16 | C Sparks | Method and apparatus for growing graft tubes in place |
US3710400A (en) * | 1971-08-30 | 1973-01-16 | C Sparks | Graft member grown in a living body |
US3908657A (en) * | 1973-01-15 | 1975-09-30 | Univ Johns Hopkins | System for continuous withdrawal of blood |
US3974526A (en) * | 1973-07-06 | 1976-08-17 | Dardik Irving I | Vascular prostheses and process for producing the same |
US6436135B1 (en) | 1974-10-24 | 2002-08-20 | David Goldfarb | Prosthetic vascular graft |
US4101984A (en) * | 1975-05-09 | 1978-07-25 | Macgregor David C | Cardiovascular prosthetic devices and implants with porous systems |
US4280954A (en) | 1975-07-15 | 1981-07-28 | Massachusetts Institute Of Technology | Crosslinked collagen-mucopolysaccharide composite materials |
GB1515963A (en) * | 1975-07-15 | 1978-06-28 | Massachusetts Inst Technology | Crosslinked collagen-mucopolysaccharide composite materials |
JPS5413694A (en) * | 1977-07-01 | 1979-02-01 | Sumitomo Electric Industries | Composite blood vessel prosthesis and method of producing same |
DE2853614A1 (en) * | 1978-01-25 | 1979-07-26 | Bentley Lab | IMPLANT |
AU516741B2 (en) * | 1978-05-23 | 1981-06-18 | Bio Nova Neo Technics Pty. Ltd. | Vascular prostheses |
JPS6037735B2 (en) * | 1978-10-18 | 1985-08-28 | 住友電気工業株式会社 | Artificial blood vessel |
SE424401B (en) * | 1979-06-06 | 1982-07-19 | Bowald S | BLODKERLSPROTES |
US4539716A (en) * | 1981-03-19 | 1985-09-10 | Massachusetts Institute Of Technology | Fabrication of living blood vessels and glandular tissues |
US4546500A (en) * | 1981-05-08 | 1985-10-15 | Massachusetts Institute Of Technology | Fabrication of living blood vessels and glandular tissues |
ATE13477T1 (en) * | 1981-07-02 | 1985-06-15 | Intermedicat Gmbh | PROCESS FOR THE PRODUCTION OF SCLEROPROTEIN TRANSPLANTS WITH INCREASED BIOLOGICAL STABILITY. |
IT1154510B (en) * | 1981-08-14 | 1987-01-21 | Bentley Lab | CONNECTOR DEVICE IMPLANTABLE IN THE BODY AND DEVICE OF VASCULAR IMPLANTATION ASSOCIATED WITH IT |
US4442133A (en) * | 1982-02-22 | 1984-04-10 | Greco Ralph S | Antibiotic bonding of vascular prostheses and other implants |
US5110852A (en) * | 1982-07-16 | 1992-05-05 | Rijksuniversiteit Te Groningen | Filament material polylactide mixtures |
NL8202894A (en) * | 1982-07-16 | 1984-02-16 | Rijksuniversiteit | POLYESTER FILAMENT MATERIAL. |
JPH0631316B2 (en) * | 1982-08-04 | 1994-04-27 | ラ ジヨラ キヤンサ− リサ−チ フアンデイシヨン | Polypeptide |
US4695281A (en) * | 1983-03-25 | 1987-09-22 | Koken Co., Ltd. | Medical material |
EP0128501B1 (en) * | 1983-06-06 | 1989-03-29 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Artificial vessel and process for preparing the same |
US4670286A (en) * | 1983-09-20 | 1987-06-02 | Allied Corporation | Method of forming prosthetic devices |
FR2556210B1 (en) * | 1983-12-08 | 1988-04-15 | Barra Jean Aubert | VENOUS PROSTHESIS AND PROCESS FOR PRODUCING THE SAME |
DE3546875C2 (en) * | 1984-01-30 | 1996-05-09 | Meadox Medicals Inc | Synthetic vascular grafts |
IL74179A (en) * | 1984-01-30 | 1992-05-25 | Meadox Medicals Inc | Collagen synthetic vascular graft |
US4842575A (en) * | 1984-01-30 | 1989-06-27 | Meadox Medicals, Inc. | Method for forming impregnated synthetic vascular grafts |
US5197977A (en) * | 1984-01-30 | 1993-03-30 | Meadox Medicals, Inc. | Drug delivery collagen-impregnated synthetic vascular graft |
US5108424A (en) * | 1984-01-30 | 1992-04-28 | Meadox Medicals, Inc. | Collagen-impregnated dacron graft |
GB2156677A (en) * | 1984-03-31 | 1985-10-16 | Wessex Medical Group Ltd | Bioprosthetic conduits |
DE169259T1 (en) * | 1984-07-25 | 1986-04-30 | Surgical Patent Products Inc. Ltd., Panama | VESSEL PROSTHESES FOR DRY STORAGE, METHOD FOR TREATMENT AND THEIR USE IN SURGERY. |
US5037377A (en) * | 1984-11-28 | 1991-08-06 | Medtronic, Inc. | Means for improving biocompatibility of implants, particularly of vascular grafts |
US4744792A (en) * | 1985-01-22 | 1988-05-17 | Richards Medical Company | Middle ear ventilating tube |
US4629458A (en) * | 1985-02-26 | 1986-12-16 | Cordis Corporation | Reinforcing structure for cardiovascular graft |
US4997440A (en) * | 1985-04-25 | 1991-03-05 | American Cyanamid Company | Vascular graft with absorbable and nonabsorbable components |
GB8516421D0 (en) * | 1985-06-28 | 1985-07-31 | Biotechnology Interface Ltd | Fibronectins |
EP0323144A3 (en) * | 1987-12-28 | 1990-05-16 | Vyzkumny Ustav Potravinarskeho Prumyslu | Method of manufacturing at least single-layer tubular blood vessel endoprosthesis, especially of a small internal diameter, and extruding nozzle for carrying out this method |
US5192311A (en) * | 1988-04-25 | 1993-03-09 | Angeion Corporation | Medical implant and method of making |
US4927410A (en) * | 1988-11-18 | 1990-05-22 | University Of South Florida | Method for fabricating prosthesis material |
US5256418A (en) * | 1990-04-06 | 1993-10-26 | Organogenesis, Inc. | Collagen constructs |
CS277367B6 (en) * | 1990-12-29 | 1993-01-13 | Krajicek Milan | Three-layered vascular prosthesis |
US5383927A (en) * | 1992-05-07 | 1995-01-24 | Intervascular Inc. | Non-thromogenic vascular prosthesis |
US20020055710A1 (en) * | 1998-04-30 | 2002-05-09 | Ronald J. Tuch | Medical device for delivering a therapeutic agent and method of preparation |
US5480423A (en) * | 1993-05-20 | 1996-01-02 | Boston Scientific Corporation | Prosthesis delivery |
EP0858298A4 (en) * | 1994-04-29 | 1999-04-07 | Boston Scient Corp | Medical prosthetic stent and method of manufacture |
EP0754017B1 (en) | 1994-04-29 | 2002-06-19 | SciMed Life Systems, Inc. | Stent with collagen |
US5928279A (en) | 1996-07-03 | 1999-07-27 | Baxter International Inc. | Stented, radially expandable, tubular PTFE grafts |
US6177609B1 (en) | 1997-03-10 | 2001-01-23 | Meadox Medicals, Inc. | Self-aggregating protein compositions and use as sealants |
US7241309B2 (en) * | 1999-04-15 | 2007-07-10 | Scimed Life Systems, Inc. | Self-aggregating protein compositions and use as sealants |
US6106454A (en) * | 1997-06-17 | 2000-08-22 | Medtronic, Inc. | Medical device for delivering localized radiation |
US6203536B1 (en) * | 1997-06-17 | 2001-03-20 | Medtronic, Inc. | Medical device for delivering a therapeutic substance and method therefor |
US6013099A (en) * | 1998-04-29 | 2000-01-11 | Medtronic, Inc. | Medical device for delivering a water-insoluble therapeutic salt or substance |
US20070031607A1 (en) * | 2000-12-19 | 2007-02-08 | Alexander Dubson | Method and apparatus for coating medical implants |
US20020084178A1 (en) * | 2000-12-19 | 2002-07-04 | Nicast Corporation Ltd. | Method and apparatus for manufacturing polymer fiber shells via electrospinning |
US20040030377A1 (en) * | 2001-10-19 | 2004-02-12 | Alexander Dubson | Medicated polymer-coated stent assembly |
US7244272B2 (en) | 2000-12-19 | 2007-07-17 | Nicast Ltd. | Vascular prosthesis and method for production thereof |
EP1377419A4 (en) * | 2001-03-20 | 2004-05-26 | Nicast Ltd | Method and apparatus of improving mechanical characteristics of nonwoven materials |
WO2005065578A2 (en) * | 2004-01-06 | 2005-07-21 | Nicast Ltd. | Vascular prosthesis with anastomotic member |
US7794490B2 (en) * | 2004-06-22 | 2010-09-14 | Boston Scientific Scimed, Inc. | Implantable medical devices with antimicrobial and biodegradable matrices |
US8029563B2 (en) * | 2004-11-29 | 2011-10-04 | Gore Enterprise Holdings, Inc. | Implantable devices with reduced needle puncture site leakage |
WO2006087721A2 (en) * | 2005-02-17 | 2006-08-24 | Nicast Ltd. | Inflatable medical device |
CA2906621A1 (en) | 2013-03-15 | 2014-09-25 | Baxter International Inc. | Immobilization of active agent on a substrate |
US9655917B2 (en) | 2013-06-07 | 2017-05-23 | Baxter International Inc. | Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups |
US9814560B2 (en) | 2013-12-05 | 2017-11-14 | W. L. Gore & Associates, Inc. | Tapered implantable device and methods for making such devices |
CN104027844A (en) * | 2014-04-04 | 2014-09-10 | 张志辉 | Novel method for coating artificial blood vessel with Astragalus polysaccharide |
CN107666882B (en) | 2015-06-05 | 2020-01-10 | W.L.戈尔及同仁股份有限公司 | Hypotonic blood volume implantable prosthesis with tapered portion |
WO2018007849A1 (en) | 2016-07-05 | 2018-01-11 | Carlos Alvarado | Serous membrane for ocular surface disorders |
CZ308556B6 (en) * | 2017-07-26 | 2020-11-25 | Vseobecna Fakultni Nemocnice V Praze | Composite vascular replacement and manufacturing method |
US11801630B2 (en) | 2017-07-28 | 2023-10-31 | Stratasys Ltd. | Method and system for fabricating object featuring properties of a blood vessel |
ES2967291T3 (en) | 2017-07-28 | 2024-04-29 | Stratasys Ltd | Additive manufacturing processes that use a material that has properties of a soft body tissue |
US11549012B2 (en) | 2017-07-28 | 2023-01-10 | Stratasys Ltd. | Formulations usable in additive manufacturing of a three-dimensional object made of a soft material |
EP3658359B1 (en) | 2017-07-28 | 2023-11-15 | Stratasys Ltd. | Method and system for fabricating object featuring properties of a hard tissue |
CN110141681B (en) * | 2019-05-24 | 2021-09-10 | 深圳齐康医疗器械有限公司 | Wound repair material for cell suspension transplantation and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB591509A (en) * | 1945-03-26 | 1947-08-20 | Raymond Nigel Roy | A soluble lumen suture support |
US3106483A (en) * | 1961-07-27 | 1963-10-08 | Us Catheter & Instr Corp | Synthetic blood vessel grafts |
US3108357A (en) * | 1962-06-20 | 1963-10-29 | William J Liebig | Compound absorbable prosthetic implants, fabrics and yarns therefor |
US3272204A (en) * | 1965-09-22 | 1966-09-13 | Ethicon Inc | Absorbable collagen prosthetic implant with non-absorbable reinforcing strands |
-
1963
- 1963-12-12 CH CH1526263A patent/CH472219A/en not_active IP Right Cessation
- 1963-12-12 DE DE1491218A patent/DE1491218C3/en not_active Expired
- 1963-12-13 BR BR155428/63A patent/BR6355428D0/en unknown
- 1963-12-16 GB GB49509/63A patent/GB1018288A/en not_active Expired
-
1964
- 1964-04-15 US US359973A patent/US3425418A/en not_active Expired - Lifetime
- 1964-06-12 BE BE649183A patent/BE649183A/xx unknown
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4416028A (en) * | 1981-01-22 | 1983-11-22 | Ingvar Eriksson | Blood vessel prosthesis |
FR2558720A1 (en) * | 1984-01-30 | 1985-08-02 | Meadox Medicals Inc | SYNTHETIC VASCULAR GRAFT, PROCESS FOR PREPARING SUCH A DISTRIBUTION GRAFT OF A MEDICAMENT COATED WITH COLLAGEN AND THINNING FOR FORMING THE SAME |
EP0183365A2 (en) * | 1984-11-30 | 1986-06-04 | Vascutek Limited | Vascular graft |
EP0183365A3 (en) * | 1984-11-30 | 1988-04-06 | J. & P. Coats, Limited | Vascular graft |
US4822361A (en) * | 1985-12-24 | 1989-04-18 | Sumitomo Electric Industries, Ltd. | Tubular prosthesis having a composite structure |
EP0230635A2 (en) * | 1985-12-24 | 1987-08-05 | Sumitomo Electric Industries Limited | Tubular prosthesis having a composite structure |
EP0230635A3 (en) * | 1985-12-24 | 1988-04-06 | Sumitomo Electric Industries Limited | Tubular prosthesis having a composite structure |
EP0237037A2 (en) * | 1986-03-12 | 1987-09-16 | B. Braun Medical AG | Vascular prosthesis impregnated with cross-linked gelatin and method of making the same |
EP0237037A3 (en) * | 1986-03-12 | 1988-04-06 | Intermedicat Gmbh | Vascular prosthesis impregnated with cross-linked gelatin and method of making the same |
US5716660A (en) * | 1994-08-12 | 1998-02-10 | Meadox Medicals, Inc. | Tubular polytetrafluoroethylene implantable prostheses |
US5851230A (en) * | 1994-08-12 | 1998-12-22 | Meadox Medicals, Inc. | Vascular graft with a heparin-containing collagen sealant |
US6162247A (en) * | 1994-08-12 | 2000-12-19 | Meadox Medicals, Inc. | Vascular graft impregnated with a heparin-containing collagen sealant |
US5986168A (en) * | 1995-04-25 | 1999-11-16 | Nicem, Ltd. | Prosthesis containing bioabsorbable materials insolubilized without chemical reagents and method of making the same |
US6129757A (en) * | 1998-05-18 | 2000-10-10 | Scimed Life Systems | Implantable members for receiving therapeutically useful compositions |
US6210436B1 (en) | 1998-05-18 | 2001-04-03 | Scimed Life Systems Inc. | Implantable members for receiving therapeutically useful compositions |
US6447542B1 (en) | 1998-05-18 | 2002-09-10 | Scimed Life Systems, Inc. | Implantable members for receiving therapeutically useful compositions |
WO2011012178A2 (en) | 2009-07-31 | 2011-02-03 | Aesculap Ag. | Tubular implant for replacing natural blood vessels |
Also Published As
Publication number | Publication date |
---|---|
US3425418A (en) | 1969-02-04 |
DE1491218B2 (en) | 1972-06-08 |
GB1018288A (en) | 1966-01-26 |
CH472219A (en) | 1969-05-15 |
BE649183A (en) | 1964-10-01 |
BR6355428D0 (en) | 1973-07-19 |
DE1491218C3 (en) | 1973-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1491218A1 (en) | Highly porous collagen tissue blood vessel prosthesis and method for producing the same | |
EP1948260B8 (en) | Composite material, especially for medical use, and method for producing the same | |
DE60018814T2 (en) | Sewable membrane for adhesion prevention | |
EP2926840B1 (en) | Method for the treatment of biological tissue for dry use in an implant | |
DE69122369T2 (en) | Three-layer vascular prosthesis | |
DE69720769T2 (en) | ARTIFICIAL NEURAL CHANNEL | |
EP0248247B1 (en) | Vascular graft wall | |
DE69525692T2 (en) | Implantable tubular prosthesis made of polytetrafluoroethylene | |
DE602004000323T2 (en) | Preparations for the restoration and regeneration of human dura mater | |
DE69425358T2 (en) | USE OF A POROUS CALCIUM CARBONATE MATERIAL AS A SUPPORT FOR A GROWTH FACTOR IN THE PRODUCTION OF A RESORBABLE IMPLANT | |
EP1948263B1 (en) | Nerve guide | |
DE60212311T2 (en) | Adhesion preventing membranes, methods of making a collagen single strand, method and apparatus for making a collagen web | |
DE10135275A1 (en) | Implant and process for its manufacture | |
DE102009060623B4 (en) | Artificial bone that is absorbable and replaceable by autogenous bone, as well as its manufacturing process | |
DE102004024635A1 (en) | Process for the preparation of moldings based on crosslinked gelatin | |
EP3165239B1 (en) | Method for reducing paravalvular leaks with decellularized tissue | |
DE69429894T2 (en) | Use of a surgical composite | |
DE102009057545A1 (en) | Artificial bone that is absorbable and replaceable by autogenous bone, as well as its manufacturing process | |
DE102005054938A1 (en) | Shaped body based on a crosslinked, gelatin-containing material, process for their preparation and their use | |
DE69327793T2 (en) | ABSORBABLE TOPICAL BLOODSTILL | |
DE3913926C2 (en) | ||
EP1957125B1 (en) | Method for producing a hollow profile using a cross-linked, gelatinous material and implants in the form of hollow profiles | |
AT241016B (en) | Highly porous collagen tissue blood vessel prosthesis and method for making the same | |
DE102005054937A1 (en) | Angiogenesis promoting substrate | |
DE102006042631A1 (en) | Implant and method for its production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SH | Request for examination between 03.10.1968 and 22.04.1971 | ||
C3 | Grant after two publication steps (3rd publication) |